Inventor · disambiguated record
Allan R. Moorman
Also filed as: MOORMAN ALLAN · MOORMAN ALLAN R
11 granted patents·10 pending applications·22 citations·filing 2002–2012
83Inventor score
Files withKING PHARMACEUTICALS RES & DEV11BARALDI PIER GIOVANNI4BOREA PIER A2MOORMAN ALLAN R2ANDRES PATRICIA M J1
Top patents by PatentIndex Score
21 records- 0177US7511133B2Adenosine A3 receptor agonistsKING PHARMACEUTICALS RES & DEV·Filed 2004·Granted Mar 31, 2009·10 cites·1 claims
- 0272US7767685B2Adenosine A2B receptor antagonistsKING PHARMACEUTICALS RES & DEV·Filed 2007·Granted Aug 3, 2010·2 cites·7 claims
- 0370US6951932B2Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosinesKING PHARMACEUTICALS RES & DEV·Filed 2002·Granted Oct 4, 2005·6 cites·80 claims
- 0468US7101905B2Pharmaceutically active compounds and methods of useKING PHARMACEUTICALS RES & DEV·Filed 2002·Granted Sep 5, 2006·4 cites·8 claims
- 0558US7723343B2Adenosine A2A receptor antagonistsKING PHARMACEUTICALS RES & DEV·Filed 2008·Granted May 25, 2010·0 cites·14 claims
- 0656US7855209B2Allosteric modulators of the A1 adenosine receptorKING PHARMACEUTICALS RES & DEV·Filed 2007·Granted Dec 21, 2010·0 cites·21 claims
- 0756US7691869B2Pyrrolotriazolopyrimidine derivatives, pharmaceutical compositions containing them and methods of treating conditions and diseases mediated by the adenosine A2A receptor activityKING PHARMACEUTICALS RES & DEV·Filed 2008·Granted Apr 6, 2010·0 cites·17 claims
- 0856US2011044904A1Crystal forms of 2--adenosineMOORMAN ALLAN R·Filed 2009·Application pending·0 cites
- 0952US7449490B2Pharmaceutically active compounds and methods of useKING PHARMACEUTICALS RES & DEV·Filed 2006·Granted Nov 11, 2008·0 cites·9 claims
- 1051US2009281145A1Allosteric enhancers of the a1 adenosine receptorBARALDI PIER GIOVANNI·Filed 2009·Application pending·0 cites
- 1148US2010324279A1Crystal forms of 2-[2-(4-chlorophenyl)ethoxy]adenosineANDRES PATRICIA M J·Filed 2008·Application pending·0 cites
- 1247US7897596B2Allosteric modulators of the A1 adenosine receptorKING PHARMACEUTICALS RES & DEV·Filed 2007·Granted Mar 1, 2011·0 cites·25 claims
- 1347US2006204502A1Enhancing treatment of cancer and HIF-1 mediated disorders with adenosine A3 receptor antagonistsBOREA PIER A·Filed 2005·Application pending·0 cites
- 1447US2006194756A1Enhancing treatment of HIF-1 mediated disorders with adenosine A3 receptor agonistsBOREA PIER A·Filed 2005·Application pending·0 cites
- 1546US7691825B2Adenosine A2B receptor agonistsKING PHARMACEUTICALS RES & DEV·Filed 2007·Granted Apr 6, 2010·0 cites·11 claims
- 1646US2009023799A1CRYSTALS OF (2-AMINO-4,5,6,7-TETRAHYDROBENZO[b]THIEN-3-YL)(4-CHLOROPHENYL)METHANONELAURENCE GEORGE·Filed 2008·Application pending·0 cites
- 1745US2013136693A1Crystal Forms of 2--AdenosineMOORMAN ALLAN R·Filed 2012·Application pending·0 cites
- 1843US2009233878A1Novel adenosine a3 receptor agonistsBARALDI PIER GIOVANNI·Filed 2008·Application pending·0 cites
- 1939US7342003B2Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogsKING PHARMACEUTICALS RES & DEV·Filed 2005·Granted Mar 11, 2008·0 cites·25 claims
- 2039US2012108636A1Allosteric Enhancers of th A1 Adenosine ReceptorBARALDI PIER GIOVANNI·Filed 2012·Application pending·0 cites
- 2136US2011053917A1Allosteric Modulators of the A1 Adenosine ReceptorBARALDI PIER GIOVANNI·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Allan R. Moorman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →